0 By Mary Dollear In Home Page Articles, Links to Lupus NewsPosted October 20, 2025FDA Approves Genentech’s Gazyva for the Treatment of Lupus NephritisFDA approval based on superiority of Gazyva over standard therapy alone, as shown in Phase II NOBILITY and Phase III REGENCY data – READ MORE